R. R. Reinert

999 total citations
18 papers, 767 citations indexed

About

R. R. Reinert is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, R. R. Reinert has authored 18 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Microbiology and 3 papers in Infectious Diseases. Recurrent topics in R. R. Reinert's work include Pneumonia and Respiratory Infections (16 papers), Bacterial Infections and Vaccines (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). R. R. Reinert is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Bacterial Infections and Vaccines (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). R. R. Reinert collaborates with scholars based in Germany, France and Slovakia. R. R. Reinert's co-authors include Anette Siedler, H.-J. Schmitt, Rüdiger von Kries, F. Rossi, Michael J. Dowzicky, Xiao Zhang, Donald E. Low, Achim Kaufhold, Helle Bossen Konradsen and Silvia Evers and has published in prestigious journals such as Clinical Infectious Diseases, European Respiratory Journal and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R. R. Reinert

18 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. R. Reinert Germany 13 602 236 161 114 86 18 767
Anne Windau United States 14 519 0.9× 234 1.0× 243 1.5× 169 1.5× 165 1.9× 21 800
Fredrik Resman Sweden 16 427 0.7× 289 1.2× 144 0.9× 115 1.0× 44 0.5× 37 701
Maria Bernadete Fernandes Chedid Brazil 7 721 1.2× 111 0.5× 70 0.4× 136 1.2× 113 1.3× 10 833
Alan T. Evangelista United States 13 565 0.9× 164 0.7× 242 1.5× 119 1.0× 283 3.3× 27 759
A W Howell United States 13 506 0.8× 213 0.9× 265 1.6× 109 1.0× 254 3.0× 17 752
Thomas Man-kit So Thailand 6 432 0.7× 128 0.5× 292 1.8× 76 0.7× 120 1.4× 8 691
Juan García-de-Lomas Spain 13 667 1.1× 155 0.7× 161 1.0× 242 2.1× 200 2.3× 17 886
Carlos Fernández-Mazarrasa Spain 11 431 0.7× 91 0.4× 200 1.2× 262 2.3× 143 1.7× 15 715
M. Khoosal South Africa 17 698 1.2× 175 0.7× 80 0.5× 267 2.3× 30 0.3× 19 982
L A Maher United States 13 636 1.1× 310 1.3× 288 1.8× 147 1.3× 310 3.6× 18 897

Countries citing papers authored by R. R. Reinert

Since Specialization
Citations

This map shows the geographic impact of R. R. Reinert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. R. Reinert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. R. Reinert more than expected).

Fields of papers citing papers by R. R. Reinert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. R. Reinert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. R. Reinert. The network helps show where R. R. Reinert may publish in the future.

Co-authorship network of co-authors of R. R. Reinert

This figure shows the co-authorship network connecting the top 25 collaborators of R. R. Reinert. A scholar is included among the top collaborators of R. R. Reinert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. R. Reinert. R. R. Reinert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Torres, Antoní, Paolo Bonanni, Waleria Hryniewicz, et al.. (2014). Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?. European Journal of Clinical Microbiology & Infectious Diseases. 34(1). 19–31. 48 indexed citations
3.
Reinert, R. R.. (2009). The antimicrobial resistance profile of Streptococcus pneumoniae. Clinical Microbiology and Infection. 15. 7–11. 105 indexed citations
4.
Reinert, R. R.. (2009). The public health ramifications of pneumococcal resistance. Clinical Microbiology and Infection. 15. 1–3. 4 indexed citations
5.
Schaaf, Bernhard, Jan Matthias Kruse, Jan Rupp, et al.. (2007). Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. European Respiratory Journal. 30(3). 517–524. 45 indexed citations
6.
Evers, Silvia, André J.H.A. Ament, Giorgio Lorenzo Colombo, et al.. (2007). Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. European Journal of Clinical Microbiology & Infectious Diseases. 26(8). 531–540. 71 indexed citations
7.
Reinert, R. R., Mark van der Linden, Adnan Al‐Lahham, et al.. (2007). Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clinical Microbiology and Infection. 13(4). 363–368. 17 indexed citations
8.
9.
Siedler, Anette, et al.. (2005). REGIONAL DIFFERENCES IN THE EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL DISEASE IN TODDLERS IN GERMANY. The Pediatric Infectious Disease Journal. 24(12). 1114–1115. 7 indexed citations
10.
Reinert, R. R.. (2004). Clinical efficacy of ketolides in the treatment of respiratory tract infections. Journal of Antimicrobial Chemotherapy. 53(6). 918–927. 30 indexed citations
11.
Reinert, R. R.. (2004). Resistance Phenotypes and Multi-drug Resistance in Streptococcus pneumoniae (PROTEKT Years 1–3 [1999–2002]). Journal of Chemotherapy. 16(sup6). 35–48. 11 indexed citations
12.
Farrell, David J., Stephen G. Jenkins, & R. R. Reinert. (2004). Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999–2000 and the in vitro efficacy of telithromycin and comparators. Journal of Medical Microbiology. 53(11). 1109–1117. 15 indexed citations
13.
Reinert, R. R.. (2002). Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones. Journal of Antimicrobial Chemotherapy. 49(6). 1015–1018. 13 indexed citations
14.
Reinert, R. R.. (2002). Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. Journal of Antimicrobial Chemotherapy. 49(1). 61–68. 97 indexed citations
15.
16.
Kries, Rüdiger von, Anette Siedler, H.-J. Schmitt, & R. R. Reinert. (2000). Proportion of Invasive Pneumococcal Infections in German Children Preventable by Pneumococcal Conjugate Vaccines. Clinical Infectious Diseases. 31(2). 482–487. 98 indexed citations
17.
Reinert, R. R., Rudolf Lütticken, & Achim Kaufhold. (1993). [Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].. PubMed. 88(6). 357–61. 9 indexed citations
18.
Kaufhold, Achim, R. R. Reinert, & W. Kern. (1992). Bacteremia caused byStomatococcus mucilaginosus: Report of seven cases and review of the literature. Infection. 20(4). 213–220. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026